Everest Medicines Limited (HKG:1952)
Hong Kong
· Delayed Price · Currency is HKD 50.45
-6.90 (-12.03%)
Jun 13, 2025, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 16.37 billion as of June 13, 2025. Its market cap has increased by 117.47% in one year.
Market Cap
16.37B
Enterprise Value
15.28B
Revenue
752.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.45
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 16.37B, a decrease of -20.67%. That is a compound annual growth rate of -4.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 18.61B | 19.36% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | 19.85B | -3.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 262.38B |
| Hansoh Pharmaceutical Group Company | 177.78B |
| Innovent Biologics | 133.37B |
| JD Health International | 130.08B |
| WuXi Biologics | 108.43B |
| CSPC Pharmaceutical Group | 103.43B |
| Sino Biopharmaceutical | 101.76B |
| Akeso | 85.67B |